Buoyed by their impressive performance, the companies are busy expanding into new products and places. Contract manufacturers ...
Binary code displayed on a laptop screen and Intel logo displayed on a phone screen are seen in this ... [+] illustration ...
The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in 4Q24, and Genenta expects to treat six ...
Under the agreement, UCB gains a non-exclusive license to leverage XtalFold for the discovery and engineering of biologics.